Managers / Q2 2025 · view latest →
INVESTOR AB
CIK 0000889232 · ARSENALSGATAN 8C, SE-103 32, STOCKHOLM, 00000 · 46-8-6142000
Summary
Investor AB reported $5.2B in U.S.-listed holdings across 13 positions for Q2 2025.
The portfolio is heavily concentrated: NDAQ alone accounts for 99.5% of reported value.
Compared with Q1 2025, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.6% · $5.2B
- Other · 0.4% · $19M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TERTERADYNE INC | NEW | +5.0K | 5.0K | +$449,600 | $449,600 |
| GATES INDUSTRIAL CORP PLC | NEW | +15.0K | 15.0K | +$345,450 | $345,450 |
| BLKBLACKROCK INC | SOLD OUT | −480 | 0 | −$454,310 | $0 |
| ICEINTERCONTINENTAL EXCHANGE IN | SOLD OUT | −1.7K | 0 | −$293,250 | $0 |
| MILLICOM INT. CELLULAR | TRIMMED | −47.0K | 20.8K | −$1M | $778,664 |
| CDNSCADENCE DESIGN SYS INC. | TRIMMED | −1.5K | 2.5K | −$246,945 | $770,375 |
| MCHPMICROCHIP TECHNOLOGY INC | ADDED | +5.0K | 25.0K | +$791,050 | $2M |
| CHECK POINT SOFTWARE TECHNOLOGIES | TRIMMED | −500 | 3.0K | −$133,970 | $663,750 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NDAQNASDAQ INChistory → | COM | 99.54% | $5.2B | 58.18M |
| 2 | MEDIWOUND LTD | SHS NEW | 0.32% | $17M | 872.1K |
| 3 | MCHPMICROCHIP TECHNOLOGY INC | COM | 0.03% | $2M | 25.0K |
| 4 | MILLICOM INT. CELLULAR | COM STK | 0.01% | $778,664 | 20.8K |
| 5 | CDNSCADENCE DESIGN SYS INC. | COM | 0.01% | $770,375 | 2.5K |
| 6 | CHECK POINT SOFTWARE TECHNOLOGIES | ORD | 0.01% | $663,750 | 3.0K |
| 7 | CELLEBRITE DI LTD | ORDINARY SHARES | 0.01% | $640,000 | 40.0K |
| 8 | CCL1EURCARNIVAL CORP. | UNIT 99/99/9999 | 0.01% | $590,520 | 21.0K |
| 9 | COHRCOHERENT CORP | COM | 0.01% | $535,260 | 6.0K |
| 10 | TERTERADYNE INC | COM | 0.01% | $449,600 | 5.0K |
| 11 | WHRWHIRLPOOL CORPORATION | COM | 0.01% | $375,254 | 3.7K |
| 12 | GATES INDUSTRIAL CORP PLC | ORD SHS | 0.01% | $345,450 | 15.0K |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC. | COM | 0.00% | $203,389 | 3.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $15.1B | 10 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $5.7B | 12 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $5.2B | 12 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $5.2B | 13 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $4.4B | 13 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $4.5B | 8 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $4.3B | 7 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $3.5B | 6 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $3.7B | 10 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $3.4B | 10 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.8B | 9 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.9B | 9 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3.2B | 7 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $3.6B | 5 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.3B | 7 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $3.0B | 5 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $3.5B | 8 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $4.1B | 7 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.7B | 4 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.4B | 3 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.9B | 2 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.6B | 3 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.4B | 7 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $2.3B | 4 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.9B | 4 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.1B | 6 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.9B | 8 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.9B | 5 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.7B | 4 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.7B | 5 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.